Subscribe to Newsletter

Small Molecules

Discovery & Development Drug Discovery

Maurice Hilleman, We Salute You

| Rob Coker | 4 min read

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Business & Regulation Standards & Regulation

Saying Farewell to the Famous Horse Tweet

| Stephanie Vine | 5 min read

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Manufacture Technology and Equipment

Extracting the Full Power of LNPs

| Catherine Jomary, Luis Martinez Darriba | 9 min read

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

Manufacture Small Molecules

Capsules: Make Way for Pastillation

| Dr Subhashis Chakraborty | 4 min read

It’s already used for processing powders in many industries, but here’s why pastillation should come to pharma next.

Discovery & Development Drug Discovery

Cooking, Computing, and Collaborating

| 4 min read

Sitting Down With Christian Baber of the Pistoia Alliance

Business & Regulation Standards & Regulation

Showdown Over the Abortion Pill in the US

| Stephanie Vine | 4 min read

The Supreme Court will decide the fate of the abortion pill mifepristone in the US on March 26, 2024.

Business & Regulation Profession

The Start of a Journey

| Stephanie Vine | 6 min read

Meet Brad Hocking – a final year PhD student at Imperial College London who is passionate about small molecule drug discovery.

Discovery & Development Small Molecules

System Addict

| 4 min read

Researchers have developed a new chemical entity that can cut alcohol consumption in half

Discovery & Development Drug Discovery

Addressing Epilepsy

| Stefanie Dedeurwaerdere | 4 min read

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Business & Regulation Business Practice

Active Manufacturing Responsibility and the Other AMR

| Marijn Verhoef, Martijn van Gerven | 5 min read

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register